Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer-Reference-Cited by-同舟云学术

Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer

Published:2021-06 Issue:5 Volume:12 Page:752-758
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Yuan Yuan,Lee Jin Sun,Yost Susan E.,Stiller Tracey,Blanchard M. Suzette,Padam Simran,Katheria Vani,Kim Heeyoung,Sun Canlan,Tang Aileen,Martinez Norma,Patel Niki Dipesh,Sedrak Mina S.,Waisman James,Li Daneng,Sanani Shamel,Presant Cary A.,Mortimer Joanne

Funder

NIH

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference60 articles.

1. Advances in HER2-targeted therapy: novel agents and opportunities beyond breast and gastric Cancer;Meric-Bernstam;Clin. Cancer Res.,2019

2. HER2-targeted treatment for older patients with breast cancer: an expert position paper from the International Society of Geriatric Oncology;Brain;J. Geriatr. Oncol.,2019

3. Targeted therapy for breast cancer in older patients;Pondé;J. Geriatr. Oncol.,2020

4. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial;Chan;Lancet Oncol.,2016

5. TBCRC 022: a phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases;Freedman;J. Clin. Oncol.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Chemotherapy for Breast Cancer in Older Adult Patients;Clinical Interventions in Aging;2024-07

2. Targeting HER2/HER3 co‐mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy;Cancer Reports;2024-03

3. Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19;Reviews in Medical Virology;2023-12-21